Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Youngji Jo

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Scientific Reports|October 28, 2025
Evaluating voluntary care seeking effects on COVID-19 outcomes and health system costsSileshi Sintayehu Sharbayta, Jaehun Jung, Youngji Jo
Journal of Korean Medical Science|August 15, 2023
A Model-Based Cost-Effectiveness Analysis of Long-Acting Monoclonal Antibody (Tixagevimab and Cilgavimab: Evusheld) Preventive Treatment for High-Risk Populations Against SARS-CoV-2 in KoreaYoungji Jo, Sun Bean Kim, Jaehun Jung
Plos One|April 6, 2026
The impact of human behavioral adaptation stratified by immune status on COVID-19 spread with application to South KoreaSileshi Sintayehu Sharbayta, Youngji Jo, Jaehun Jung, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|July 5, 2026
Time to Recovery from Long COVID: A Longitudinal Analysis of Symptom Duration and Risk Factors Using Accelerated Failure Time ModelsYoungji Jo, Zeyu Hu, Hyejin Joo, et al.
Journal of Korean Medical Science|June 14, 2022
Optimal Social Distancing Policy for COVID-19 Control in Korea: A Model-Based AnalysisYoungji Jo, Sourya Shrestha, Munkhzul Radnaabaatar, et al.
Scientific Reports|July 7, 2025
Dynamic interactions of COVID-19 incidences, mobility, and social distancing policies in seoul: A VAR model approachZeyu Hu, Won Chang, Youngook Jang, et al.
Journal of the International AIDS Society|February 12, 2025
Integrated multi-month dispensing for HIV and hypertension in South Africa: A model of epidemiological impact and cost-effectivenessYoungji Jo, Sydney Rosen, Brooke E Nichols, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 26, 2020
Model-based Cost-effectiveness of State-level Latent Tuberculosis Interventions in California, Florida, New York, and TexasYoungji Jo, Sourya Shrestha, Isabella Gomes, et al.
Journal of the International AIDS Society|October 27, 2020
Cost-effectiveness of a 12 country-intervention to scale up short course TB preventive therapy among people living with HIVHyejeong Shin, Youngji Jo, Richard E Chaisson, et al.
Journal of the International AIDS Society|October 19, 2020
Cost-effectiveness of one month of daily isoniazid and rifapentine versus three months of weekly isoniazid and rifapentine for prevention of tuberculosis among people receiving antiretroviral therapy in UgandaOlivia Ferguson, Youngji Jo, Jeff Pennington, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Scientific Reports|October 28, 2025
Evaluating voluntary care seeking effects on COVID-19 outcomes and health system costsSileshi Sintayehu Sharbayta, Jaehun Jung, Youngji Jo
Journal of Korean Medical Science|August 15, 2023
A Model-Based Cost-Effectiveness Analysis of Long-Acting Monoclonal Antibody (Tixagevimab and Cilgavimab: Evusheld) Preventive Treatment for High-Risk Populations Against SARS-CoV-2 in KoreaYoungji Jo, Sun Bean Kim, Jaehun Jung
Plos One|April 6, 2026
The impact of human behavioral adaptation stratified by immune status on COVID-19 spread with application to South KoreaSileshi Sintayehu Sharbayta, Youngji Jo, Jaehun Jung, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|July 5, 2026
Time to Recovery from Long COVID: A Longitudinal Analysis of Symptom Duration and Risk Factors Using Accelerated Failure Time ModelsYoungji Jo, Zeyu Hu, Hyejin Joo, et al.
Journal of Korean Medical Science|June 14, 2022
Optimal Social Distancing Policy for COVID-19 Control in Korea: A Model-Based AnalysisYoungji Jo, Sourya Shrestha, Munkhzul Radnaabaatar, et al.
Scientific Reports|July 7, 2025
Dynamic interactions of COVID-19 incidences, mobility, and social distancing policies in seoul: A VAR model approachZeyu Hu, Won Chang, Youngook Jang, et al.
Journal of the International AIDS Society|February 12, 2025
Integrated multi-month dispensing for HIV and hypertension in South Africa: A model of epidemiological impact and cost-effectivenessYoungji Jo, Sydney Rosen, Brooke E Nichols, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 26, 2020
Model-based Cost-effectiveness of State-level Latent Tuberculosis Interventions in California, Florida, New York, and TexasYoungji Jo, Sourya Shrestha, Isabella Gomes, et al.
Journal of the International AIDS Society|October 27, 2020
Cost-effectiveness of a 12 country-intervention to scale up short course TB preventive therapy among people living with HIVHyejeong Shin, Youngji Jo, Richard E Chaisson, et al.
Journal of the International AIDS Society|October 19, 2020
Cost-effectiveness of one month of daily isoniazid and rifapentine versus three months of weekly isoniazid and rifapentine for prevention of tuberculosis among people receiving antiretroviral therapy in UgandaOlivia Ferguson, Youngji Jo, Jeff Pennington, et al.
Pageof 4